Q&A: The transition to Pharma 5.0

March 27, 2026

Remove from favorites

Add to favorites

This interview explores how the pharmaceutical industry is evolving beyond Pharma 4.0 — which focused on digitalization and operational efficiency — into Pharma 5.0, a paradigm that emphasizes human-centric technology, sustainability, and resilience in manufacturing and supply chains. In the Pharma 5.0 model, digital tools don’t just automate tasks; they augment human work to improve decision-making, efficiency, and sustainability outcomes. Experts interviewed highlight barriers to digital transformation — including skill shortages, organizational resistance, and integration challenges — and describe how technologies like real-time monitoring, predictive analytics, and advanced digital platforms support operational gains (e.g., water and energy use reductions) while also aligning with environmental and business performance goals. The conversation also covers practical adoption of advanced digital tools such as digital twins, AI, and secure data systems (e.g., blockchain) to enhance process accuracy and traceability, noting that successful Pharma 5.0 implementation requires focusing on real-world problems and ensuring digital records truly reflect physical operations rather than technology for its own sake.